Is Clover Health a Disruptor or Distractor?

Clover Health (NASDAQ: CLOV) has been one of the most controversial Medicare insurance providers since being brought public by Social Capital and Hedosophia. In this episode of Industry Focus: Wildcard, Motley Fool contributor Jason Hall and analyst Emily Flippen discuss Clover's business and its unique value proposition, and then debate whether the controversial short-seller report should have investors running for the door. To catch full episodes of all The Motley Fool's free podcasts, check out our podcast center.